Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Hydroxyurea × 30 days × Clear all

Phase

Phase 1 3 Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycythemia Vera 1

Interventions

Tamoxifen 4 Letrozole 4 Anastrozole 4 ribociclib 3 exemestane 3 trametinib 2 dabrafenib 2 atezolizumab 2 Vancomycin 2 Rituximab 2 Nivolumab 2 Ipilimumab 2 Fulvestrant 2 Carboplatin 2 Blood Specimen Collection 2 Bevacizumab 2 toripalimab 1 tislelizumab 1 sofosbuvir-velpatasvir drug combination 1 rozanolixizumab 1 relatlimab 1 ravulizumab 1 radium Ra 223 dichloride 1 pirtobrutinib 1 pembrolizumab 1 pazopanib 1 palbociclib 1 olutasidenib 1 obinutuzumab 1 nirogacestat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05853458 2026-04-07

HU-F-AIM

Novartis

Phase 4 Terminated

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡